ReWalk Robotics Ltd

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

ReWalk Robotics reports robust Q1 results and plans for growth

ReWalk Robotics (LFWD) delivered strong Q1 2024 results, driven by Medicare claims approval and a focus on growth strategies.
Despite challenges in gross profit and operating expenses, the company's solid financial position and market development goals position it well for future success.
Opportunities lie in new product launches, increased interest in Medicare reimbursement, and strategic initiatives to drive revenue growth and profitability.

ReWalk Robotics reports record revenue in Q2 2024

ReWalk Robotics demonstrated strong financial performance in Q2 2024, driven by successful product placements and revenue growth.
While facing challenges in managing expenses and achieving gross margin targets, the company is well-positioned for future growth.
With a focus on innovation, market expansion, and cost efficiencies, ReWalk Robotics aims to capitalize on opportunities in the exoskeleton systems market.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Lifeward Ltd. Is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Yokneam Ilit, Israel.

Following approval by the shareholders and the Israel Companies Registrar, Lifeward has completed is rebranding initiative with a formal name change of the parent company in Israel Following approval by the shareholders and the Israel Companies Registrar, Lifeward has completed is rebranding initiative with a formal name change of the parent company in Israel

ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd.

A past-president of the American Spinal Injury Association, Dr. Tansey brings Lifeward over 30 years of experience in research and treatment of spinal cord injuries as a practicing Physician, Professor, and Research Scientist A past-president of the American Spinal Injury Association, Dr. Tansey brings Lifeward over 30 years of experience in research and treatment of spinal cord injuries as a practicing Physician, Professor, and Research Scientist

Lifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research

As part of the fundraising “Step Challenge”, ReWalk users in Germany completed 424,844 steps to raise 5,000 Euros for the European Spinal Cord Injury Federation (“ESCIF”) As part of the fundraising “Step Challenge”, ReWalk users in Germany completed 424,844 steps to raise 5,000 Euros for the European Spinal Cord Injury Federation (“ESCIF”)

Lifeward's First Annual Step Challenge Donates €5,000 to German Association for People Living with Spinal Cord Injury

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Sept. 04, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions in rehabilitation, and recovery, announced that Larry Jasinski, Chief Executive Officer, will present and host one-on-one meetings with investors at the H.C. Wainwright 26th Annual Global Investment Conference on September 9-11, 2024 at the Lotte New York Palace Hotel in New York City.

Lifeward to Present at the H.C. Wainwright 26th Annual Global Investment Conference

ReWalk Robotics Ltd. (NASDAQ:LFWD ) Q2 2024 Earnings Conference Call August 15, 2024 8:30 AM ET Company Participants Mike Lawless - Chief Financial Officer Larry Jasinski - Chief Executive Officer Conference Call Participants Swayampakula Ramakanth - H.C.

ReWalk Robotics Ltd. (LFWD) Q2 2024 Earnings Call Transcript

ReWalk Robotics (LFWD) came out with a quarterly loss of $0.50 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to loss of $0.35 per share a year ago.

ReWalk Robotics (LFWD) Reports Q2 Loss, Lags Revenue Estimates

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Aug. 08, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life's passions in the face of physical limitation or disability, today announced that the Company will release its second quarter 2024 financial results before the markets open on Thursday, August 15, 2024.

Lifeward to Report Second Quarter Financial Results on August 15, 2024

Ekso Bionics Hlds

Myomo

An exciting, under-the-radar development is unfolding. I'm referring to the development of Robotic Exoskeletons, a phenomenon that could literally be life-changing to some.

The 3 Best Robotic Exoskeleton Stocks to Buy Now

Jeff Dykan, who led Lifeward as Chairman of its Board through the past 15 years, has announced his intent to retire at the end of his current term Jeff Dykan, who led Lifeward as Chairman of its Board through the past 15 years, has announced his intent to retire at the end of his current term

Lifeward Announces Appointment of Joseph E. Turk as Incoming Chairman of its Board of Directors

The AlterG NEO combines updated user-friendly design with trusted Anti-Gravity technology for precise and consistent unweighting in physical rehabilitation and athletic training

Lifeward Unveils Newest Addition to Its AlterG Anti-Gravity Product Line – Introducing AlterG NEO

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 04, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life's passions in the face of physical limitation or disability, today announced that Larry Jasinski, Chief Executive Officer, and Mike Lawless, Chief Financial Officer, will present and host one-on-one meetings with investors at the Sidoti Small Cap Conference, taking place on June 12-13, 2024.

Lifeward to Present at Sidoti Virtual Investor Conference on June 12

ReWalk Robotics Ltd. (NASDAQ:LFWD ) Q1 2024 Earnings Conference Call May 15, 2024 8:30 AM ET Company Participants Mike Lawless - CFO Larry Jasinski - CEO Conference Call Participants Swayampakula Ramakanth - H.C.

ReWalk Robotics Ltd. (LFWD) Q1 2024 Earnings Call Transcript

ReWalk Robotics (LFWD) came out with a quarterly loss of $0.73 per share versus the Zacks Consensus Estimate of a loss of $0.70. This compares to loss of $0.49 per share a year ago.

ReWalk Robotics (LFWD) Reports Q1 Loss, Misses Revenue Estimates

Q1'24 revenue of $5.3M is up 340% vs. Q1'23 and at the midpoint of Lifeward's guidance range Newly established Medicare payment for ReWalk Personal Exoskeleton favorably impacts Q1'24 results Medicare Administrative Contractors (“MACs”) approve 14 claims since fee schedule established MARLBOROUGH, Mass.

Lifeward Reports First Quarter 2024 Financial Results

ReWalk (LFWD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

ReWalk (LFWD) Upgraded to Strong Buy: Here's What You Should Know

Garmin

Option Care Health

Invest in companies like Option Care Health (OPCH), ReWalk Robotics Ltd. (LFWD) and Garmin (GRMN), as they boast higher efficiency levels.

3 Stocks Backed by High Efficiency to Strengthen Your Portfolio

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 07, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life's passions in the face of physical limitation or disability, today announced that the Company will release its first quarter 2024 financial results before the markets open on Wednesday, May 15, 2024.

Lifeward to Report First Quarter Financial Results on May 15, 2024

ReWalk (LFWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: ReWalk Robotics (LFWD) Q1 Earnings Expected to Decline

Lifeward's (LFWD) first-quarter 2024 results are expected to reflect the benefits of several milestone achievements from last year.

Should Lifeward (LFWD) be in Your Portfolio Ahead of Q1 Earnings?

ReWalk (LFWD) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Bears are Losing Control Over ReWalk (LFWD), Here's Why It's a 'Buy' Now

Experienced healthcare and rehabilitation technology professional brings more than 30 years of experience in commercialization and new business development Experienced healthcare and rehabilitation technology professional brings more than 30 years of experience in commercialization and new business development

Lifeward Announces the Appointment of Mike Swinford to its Board of Directors

Finalized Medicare reimbursement pathway for personal exoskeletons expands access for all eligible Medicare beneficiaries Finalized Medicare reimbursement pathway for personal exoskeletons expands access for all eligible Medicare beneficiaries

Medicare Revises 2024 Fee Schedule to Include Payment Rate for the ReWalk Personal Exoskeleton

Cemex SAB de CV

SunCoke Energy

Opportunities frequently appear out of nowhere when underdog businesses triumph against the odds thanks to shrewd planning and forethought. The companies on this list all embody the spirit of the underdog, even though they operate in different industries.

Unleashing the Underdogs: 3 Hidden Gems Set to Conquer the Market

Collaboration with CMS on final payment rate focuses on commercial transaction values for the latest generation of ReWalk Exoskeleton

Lifeward CEO Issues Open Letter to Shareholders on Progress to Finalize Exoskeleton Medicare Payment Rate

Bicameral legislation seeks to codify annual examinations and assessments for assistive technologies, including Personal Exoskeletons, for Veterans with Spinal Cord Injury Bicameral legislation seeks to codify annual examinations and assessments for assistive technologies, including Personal Exoskeletons, for Veterans with Spinal Cord Injury

News for ReWalk Robotics Ltd Stock (LFWD)